Amy Tang 唐艳旻
Amy previously worked in Morningside Ventures for 13 years since 2002. She was in charge of Beijing office and invested and managed dozens of early staged biotech portfolios during this period. Up till now, most of the investments have exited via IPOs or M&A with multiple returns.
Prior to joining Morningside, she worked in GSK as regulatory manager for 5 years and product manager for 2 years.
Amy got her master degree in Chinese Academy of Sciences and bachelor degree from Shen Yang Pharmaceutical University. She is also a graduate of EMBA course of Cheung Kong Graduate School of Business (CKGSB).